Astrana Health (ASTH) Enterprise Value (2010 - 2026)

Astrana Health has disclosed Enterprise Value across 17 years of filings, most recently posting -$463.5 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$463.5 million, up 6.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$463.5 million (up 6.12% YoY), and the FY2025 annual result was -$415.5 million, up 15.79% from the prior year.
• Enterprise Value came in at -$463.5 million for Q1 2026 at Astrana Health, down from -$415.5 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$177.1 million in Q3 2022 to a low of -$575.7 million in Q2 2025.
• The 5-year median for Enterprise Value is -$449.9 million (2025), against an average of -$396.8 million.
• Across the five-year window, Enterprise Value gained 27.26% in 2022 and sank 113.43% in 2024, its largest moves.
• Astrana Health's Enterprise Value stood at -$279.4 million in 2022, then plunged by 79.77% to -$502.2 million in 2023, then climbed by 1.75% to -$493.4 million in 2024, then climbed by 15.79% to -$415.5 million in 2025, then decreased by 11.55% to -$463.5 million in 2026.
• The last three Enterprise Value figures came in at -$463.5 million (Q1 2026), -$415.5 million (Q4 2025), and -$449.9 million (Q3 2025), per Business Quant data.